Skip to main content

Table 1 Characteristics of patients with and without coronary dilatation during their acute KD phase

From: Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease

 

All (169)

Normal (138)

Dilatation (31)

P value

Male gender

99 (59%)

81 (59%)

18 (58%)

0.949

Age (yr)

1.44 (0.67; 2.56)

1.46 (0.71; 2.74)

1.12 (0.36; 2.09)

0.063

IVIG unresponsive

20 (12%)

11 (8%)

9 (29%)

0.001

Days of fever before IVIG use

5 (5; 6)

5 (4.3; 6)

5 (5; 6.3)

0.518

Albumin (g/dL)

3.9 (3.5; 4.3)

4 (3.6; 4.3)

3.5 (3.2; 4.2)

0.03

AST (U/L)

38 (29; 66.5)

37 (29; 71.5)

39.5 (25.3; 56.3)

0.379

CRP (mg/dL)

7.23 (2.22; 14.15)

6.1 (3.26; 11.93)

14.05 (6.38; 18.29)

0.009

WBC (k/μL)

13.74 (10.32; 17.56)

13.61 (10.29; 16.94)

15.36 (10.74; 19.64)

0.418

 Seg (%)

62.3 (51.3; 73.6)

62.9 (53.5; 73.9)

59 (49.7; 72)

0.391

Hb (g/dL)

11.1 (10.4; 12)

11.2 (10.5; 12)

10.9 (10.4; 11.8)

0.329

PLT (k/μL)

333 (260; 412)

328 (260; 405)

343 (253; 454)

0.285

  1. Values are expressed as medians (IQRs) and percentages (%). IVIG intravenous immunoglobulin, AST Aspartate aminotransferase, CRP C-reactive protein, WBC White blood cell, Seg Neutro segment WBC, Hb hemoglobin, PLT platelet